How severe can COPD or emphysema become and what are the advanced stages? 

The severity of Chronic Obstructive Pulmonary Disease ‘COPD’ and emphysema is typically categorised into stages ranging from mild to very severe. As the condition progresses, the damage to the airways and lung tissue becomes more extensive, leading to a significant impact on daily life and physical independence. Understanding these stages is essential for managing expectations and tailoring medical treatment to preserve as much lung function as possible. 

What We Will Cover in This Article 

• The standard criteria for staging respiratory severity 

• Physical signs of advancing emphysema and COPD 

• How lung function tests determine the stage of disease 

• Complications associated with advanced respiratory failure 

• Treatment goals for the very severe stages of the condition 

• Emergency guidance for severe breathing distress 

The progression of COPD and emphysema 

The severity of COPD or emphysema is determined by both clinical measurements and how the symptoms affect a person’s daily life. As the disease moves through different stages, the walls of the air sacs continue to break down and the airways become more prone to collapsing during exhalation. In the advanced stages, the lungs can become ‘hyperinflated’, meaning they stay partially filled with stale air that the person cannot easily breathe out. 

Clinical teams often use a system that looks at the Forced Expiratory Volume ‘FEV1’, which is the amount of air a person can forcefully blow out in one second. This is compared against the average for a healthy person of the same age and height. 

Understanding the stages of severity 

The stages of COPD and emphysema are generally divided into four categories. While everyone progresses at a different rate, these stages provide a framework for medical professionals to decide which medications, such as long acting bronchodilators or oxygen therapy, are most appropriate. 

Stage	Severity	Typical Lung Function	Daily Impact
Stage 1	Mild	80% or more of normal	Slight cough, often unnoticed
Stage 2	Moderate	50% to 79% of normal	Breathlessness when walking fast
Stage 3	Severe	30% to 49% of normal	Frequent flare ups, limited activity
Stage 4	Very Severe	Less than 30% of normal	Constant breathlessness, heart strain

Advanced stages and systemic effects 

In the advanced or ‘very severe’ stage of emphysema, the condition affects more than just the lungs. Because the body is struggling to maintain oxygen levels, other organs begin to feel the strain. People in the advanced stages may require supplemental oxygen therapy to help them maintain adequate oxygen levels in their blood and reduce the workload on their heart. 

Common features of advanced disease include: 

• Significant weight loss: The body uses a huge amount of energy just to breathe. 

• Morning headaches: This can be a sign that carbon dioxide is building up in the blood overnight. 

• Cyanosis: A bluish tint to the lips or fingernails due to low oxygen levels. 

• Oedema: Swelling in the legs and ankles caused by the heart struggling to pump blood through the lungs. 

Differentiating between severe and very severe stages 

While both stage 3 ‘Severe’ and stage 4 ‘Very Severe’ represent significant illness, there are clear differences in how they impact a person’s life and the type of medical support required. 

Aspect	Stage 3 ‘Severe’	Stage 4 ‘Very Severe’
Physical Activity	Able to walk short distances	Breathless while dressing or talking
Hospitalisation	May occur during flare ups	Frequent or prolonged stays common
Oxygen Needs	Often not required yet	Frequently required long term
Lung Appearance	Visible damage on scans	Significant hyperinflation and bullae

To Summarise 

The severity of COPD and emphysema ranges from mild symptoms that are easily managed to advanced stages that require intensive support and oxygen therapy. Monitoring the progression through regular lung function tests allows for timely adjustments to treatment. Even in advanced stages, pulmonary rehabilitation and specialised medications can improve comfort and daily function. 

If you experience severe, sudden, or worsening symptoms, such as an inability to catch your breath even at rest or feeling extremely confused, call 999 immediately. 

Authority Snapshot 

The clinical grading of respiratory severity is based on international standards adopted by the NHS and NICE to ensure consistent patient care. The information regarding FEV1 measurements and the systemic effects of advanced lung disease is derived from established clinical practice in respiratory failure and chronic disease management. This content has been developed to provide a clear understanding of disease progression and is reviewed by medical professionals to ensure accuracy and safety for those living with chronic lung conditions. 

Dr. Stefan Petrov is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support ‘BLS’, Advanced Cardiac Life Support ‘ACLS’, and the UK Medical Licensing Assessment ‘PLAB 1 & 2’. He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.